Concept Development of the Eindhoven Diabetes Education Simulator Project.
Anne H Maas, Pieta van der Molen, Reinier van de Vijver...
https://pubmed.ncbi.nlm.nih.gov/26871654/Actively Recruiting
Led by Maxima Medical Center · Updated on 2026-09-10
30
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating SugarVita 2.0, a serious digital game designed to support adults with type 2 diabetes in managing their condition. This 12-week pilot study aims to assess the usability of the game and its impact on diabetes self-management, confidence, distress, knowledge, and blood sugar control. SugarVita 2.0 uses interactive gameplay and a semi-personalized glucose simulator to provide educational feedback. Participants will use SugarVita 2.0 following a structured schedule during the first six weeks, they will play at least three times per week completing weekly challenges weeks 7 to 10 involve playing at least twice weekly without challenges, and the final two weeks allow unrestricted play. The game focuses on decisions about nutrition, physical activity, and medication, with visual feedback to help players learn. Throughout the study, participants will complete questionnaires and provide clinical data such as HbA1c before and after the intervention. Researchers will measure changes in diabetes confidence, self-management abilities, distress levels, knowledge, and blood sugar control. User engagement, including playing time and session frequency, will also be tracked to evaluate usability. The total participation lasts 12 weeks.
CONDITIONS
A Twelve-Week Pilot Study Evaluating the Usability and Preliminary Effects of SugarVita 2.0 in Adults With Type 2 Diabetes
D
Dr. Pleun Wouters-van Poppel, PhD
E
Edouard Reinders, MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Maxima Medical Center
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 12 weeks
Participants use SugarVita 2.0 according to a set schedule: playing at least three times weekly with challenges during the first six weeks, twice weekly without challenges during weeks 7 to 10, and unrestricted play during the last two weeks.
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Anne H Maas, Pieta van der Molen, Reinier van de Vijver...
https://pubmed.ncbi.nlm.nih.gov/26871654/R Duraiswami, A T Kalghatgi, S Kumaravelu
https://pubmed.ncbi.nlm.nih.gov/28769524/Maxima Medical Center
Lead Sponsor